Active Biotech AB Release: Laquinimod Highlights From Teva Pharmaceutical Industries Limited Investor Day December 11

Published: Dec 12, 2012

Lund, Sweden, December 12, 2012 - Active Biotech's (NASDAQ OMX NORDIC: ACTI) partner Teva Pharmaceutical Industries Ltd. hosted yesterday, December 11, 2012, an investor meeting. Teva has a license to develop and commercialize Active Biotech's molecule laquinimod.

Back to news